DHEA claims from @hormonespecialist get mostly right

What did @hormonespecialist actually say?

The creator opens by calling DHEA "the hormone you most likely never heard of" and then packs an enormous number of claims into a short video. The list includes reduced visceral fat, improved insulin sensitivity, better memory, restored sexual vitality, increased bone density, reduced depression, and immune optimization. They also provide specific target lab ranges, "200 to 250" for women and "500 to 600" for men on DHEAS, along with age-tiered dosing starting at 5 to 10 milligrams for women over 40 and climbing to 25 milligrams for women over 60. Men get a flat 50 milligrams, bumped to 75 to 100 milligrams for those over 200 pounds. They also flag hormone-sensitive cancers as a contraindication, recommend "sustained release, micronized DHEA," and say to recheck labs every 30 days until levels stabilize.

That is a lot of ground to cover, and the specificity of the dosing advice, particularly the weight-based adjustment for men, invites scrutiny about whether it is grounded in clinical evidence or educated extrapolation.

Does the science back this up?

Partially. DHEA is genuinely the most abundant circulating steroid in humans, and the age-related decline, starting in the mid-20s and dropping sharply by the 60s and 70s, is well-documented. But the clinical evidence for most of the benefits listed here is thinner than the video implies.

A 2020 systematic review by Peixoto et al. in Experimental Gerontology found modest benefits for mood and well-being in older adults with low DHEA, but noted heterogeneity across trials. The ECHO trial (Nair et al., 2006, NEJM) is one of the largest randomized trials on DHEA supplementation in older adults and found minimal effects on body composition, muscle strength, or insulin sensitivity after two years. That directly contradicts some of the more confident claims here about visceral fat and insulin sensitivity.

Bone density has slightly better support. A 2002 RCT by Jankowski et al. in Journal of Clinical Endocrinology and Metabolism showed improved bone mineral density in older women with low DHEAS. The menopause-specific data for intravaginal DHEA (prasterone) is solid, but that is a different delivery method than what is being described here.

What did they get wrong (or right)?

They got the basic physiology right. DHEA is a precursor to both testosterone and estradiol, and the claim that "for women in menopause, it's now your chief source of testosterone" is consistent with what reproductive endocrinologists understand about post-menopausal androgen production. Credit where it is due.

The contraindication for hormone-sensitive cancers is also appropriate and important to include. Not every creator bothers with safety caveats, so flagging breast and prostate cancer is responsible.

But the dosing advice is where this gets problematic. There is no peer-reviewed consensus supporting the specific tiered dosing presented here, particularly the weight-based adjustment for men. The commonly studied research doses range from 25 to 50 milligrams, and the 100 milligram figure for heavier men lacks clinical trial support. The claim that DHEA "reduces visceral fat" oversimplifies a literature that is, at best, mixed. And presenting a highly specific DHEAS target range of "200 to 250" for women as a universal goal ignores significant individual variability in what is considered optimal.

What should you actually know?

DHEA supplementation is not benign. At higher doses it can convert to estrogen or testosterone in amounts that matter clinically, which means androgenic side effects like acne, hair loss, and mood changes are real possibilities, not just minor footnotes. The creator does mention watching for acne, which is a fair warning, but the broader risk profile deserves more airtime.

If you are curious about your DHEAS level, getting it tested is reasonable as part of a broader hormone workup. But interpreting those results and deciding whether to supplement should happen in conversation with a clinician who knows your full health picture, not based on a TikTok target range. DHEA is also sold over the counter in the United States, which means it is not subject to the same regulatory oversight as prescription medications. Quality and actual dose content in OTC supplements vary considerably, which makes the "sustained release, micronized" recommendation harder to act on safely without medical guidance. The "recheck every 30 days" advice is practical if you are working with a provider, but self-monitoring without clinical oversight has real limits.